Precision Pharma Services AS
ASDissolvedOrg 826390972Øvre Kråkenes 17, 5152 BønesWholesale of pharmaceutical and medical goods· NACE 4646Est. 2020 · 5 years old0 employees
Loading company…
Overview
Precision Pharma Services AS is a Norwegian AS based in Bønes, operating in the Wholesale of pharmaceutical and medical goods sector. Incorporated in 2020, the company has 0 employees and reported revenue of NOK 0 in its latest annual filing.
Revenue 2020
0K NOK
EBITDA margin
—
Net profit 2020
0K NOK
0 employees
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
81.4 %
Very strongAmong the 20% highest rated companies in the industry
20202020
Liquidity ratioCurrent assets ÷ Short-term debt
5.4×
Very strongAmong the 20% highest rated companies in the industry
20202020
Return on assets (ROA)Net profit ÷ Total assets × 100
0.0 %
WeakAmong the 40% lowest rated companies in the industry
20202020
EBITDA — year on year
NOKKey figures
Annual report 2020| Revenue | 0K NOK | — |
| EBITDA | 0K NOK | — |
| Net profit | 0K NOK | — |
| Total assets | 30K NOK | — |
| Equity | 24.4K NOK | — |
| Employees | 0 | — |
Company information
Legal name
PRECISION PHARMA SERVICES AS
Org number
826390972
Legal form
Aksjeselskap
NACE code
Founded
17 December 2020 · 5 years
Share capital
—
Employees
0 (FTE)
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Address
Øvre Kråkenes 17, 5152 Bønes
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2020), Precision Pharma Services AS reported revenue of NOK 0. The bottom line showed a break-even result.
At the end of 2020, equity financed 81.4% of the balance sheet, and current assets covered short-term debt 5.4 times.
Financials
Revenue
NOKEBITDA
NOKIncome statement
NOK thousands| Item | 2020 |
|---|---|
| Revenue | 0 |
| Staff expenses | -0 |
| EBITDA | 0 |
| Depreciation & amort. | -0 |
| EBIT | 0 |
| Net financials | 0 |
| Profit before tax | 0 |
| Tax | -0 |
| Net profit | 0 |
Get a credit rating – not just the numbers
Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.
Balance sheet
NOK thousands| Item | 2020 |
|---|---|
| Total assets | 30 |
| Equity | 24 |
| Long-term debt | 0 |
| Short-term debt | 6 |
| Total debt | 6 |
Financial ratios
5-year trendEBITDA margin
0.0 %
20202020
Equity ratio
81.4 %
Very strongAmong the 20% highest rated companies in the industry
20202020
Return on equity
0.0 %
WeakAmong the 40% lowest rated companies in the industry
20202020
Net profit margin
0.0 %
20202020
Asset turnover
0.00×
Very weakAmong the 10% lowest rated companies in the industry
20202020
Debt / equity
0.23×
Very strongAmong the 20% highest rated companies in the industry
20202020
Sector performance
17 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Return on equity (ROE)Weak
Among the 40% lowest rated companies in the industry
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on assets (ROA)Weak
Among the 40% lowest rated companies in the industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Return on net assets (RONA)Weak
Among the 40% lowest rated companies in the industry
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Basic earning power (BEP)Average
Around the average of companies in the same industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Gross marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Capacity ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Liquidity
Current ratioVery strong
Among the 20% highest rated companies in the industry
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioVery strong
Among the 20% highest rated companies in the industry
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioVery strong
Among the 10% highest rated companies in the industry
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Current assets to equityStrong
Among the 40% highest rated companies in the industry
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalVery strong
Among the 10% highest rated companies in the industry
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash conversion ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Debt & solvency
Solidity ratioVery strong
Among the 20% highest rated companies in the industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Debt ratioVery strong
Among the 20% highest rated companies in the industry
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Debt to equityVery strong
Among the 20% highest rated companies in the industry
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Liabilities to equityStrong
Among the 30% highest rated companies in the industry
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Income to debtWeak
Among the 40% lowest rated companies in the industry
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtAverage
Around the average of companies in the same industry
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest coverageNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The ability to pay the interest on the company's debt out of its earnings.
Interest rate on debtNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Efficiency & development
Asset turnoverVery weak
Among the 10% lowest rated companies in the industry
Revenue relative to total assets — the ability to generate revenue from the asset base.
Equity to contributed capitalWeak
Among the 30% lowest rated companies in the industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
Inventory turnoverNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
One-year change in equityNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The size of this year's increase or decrease in the company's equity.
One-year change in debtNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The size of this year's increase or decrease in the company's debt.
Annual reports & filings
People & ownership
Management
Actively employed in the businessNo data on file.
Board of directors
Non-executive oversight| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PM Chairman | Chairman | 2021 |
Former (2)
TJ Chairman | Chairman | 2021 – 2021 |
MH Board of Directors | Board of Directors | 2021 – 2022 |
Shareholders
Active legal owners| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Company | 100% | 100% | 2020 |
One in three Danish companies experiences fraud
Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.
Related companies
Company hierarchy
Shape Services As
Precision Pharma Services AS Board network connections
Board members of Precision Pharma Services AS also hold positions in 43 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Trym Jacobsen | Chairman | 32 companiesMany roles |
| Morten Hilton Thomassen | Board of Directors | 11 companiesMany roles |
Frequently asked questions
What is the Org number of Precision Pharma Services AS?
Precision Pharma Services AS is registered with Brønnøysundsregistrene under Org 826390972.
Who is the chairman of Precision Pharma Services AS?
Parth Mukeshbhai Ray chairs the board of Precision Pharma Services AS, in role since 2021.
Where is Precision Pharma Services AS headquartered?
Precision Pharma Services AS's registered address is Øvre Kråkenes 17.